StonvexLoading…
StonvexCore line items from RPRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.38B | $2.26B | $2.35B | $2.24B |
Operating Income | $1.56B | $1.29B | $1.49B | $307.06M |
Net Income | $770.95M | $858.98M | $1.13B | $42.83M |
EPS (Diluted) | $1.78 | $1.91 | $2.53 | $0.10 |
Total Assets | $19.62B | $18.22B | $16.38B | $16.81B |
Total Liabilities | $9.91B | $7.88B | $6.30B | $7.29B |
Cash & Equivalents | $618.70M | $929.03M | $477.01M | $1.71B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 564.46M | 594.11M | 602.90M | 437.97M |